DOCSLIB.ORG

Integrative Analysis of HIF Binding and Transactivation Reveals Its Role in Maintaining Histone Methylation Homeostasis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Integrative Analysis of HIF Binding and Transactivation Reveals Its Role in Maintaining Histone Methylation Homeostasis Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis Xiaobo Xiaa, Madeleine E. Lemieuxa, Wei Lib,c,1, Jason S. Carrolld,2, Myles Brownd, X. Shirley Liub,c, and Andrew L. Kunga,e,3 Departments of aPediatric Oncology, bBiostatistics and Computational Biology, and dMedical Oncology, Dana–Farber Cancer Institute, 44 Binney Street, and Harvard Medical School, Boston, MA 02115; cHarvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115; and eDivision of Pediatric Hematology/Oncology, Children’s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115 Edited by Steven L. McKnight, University of Texas Southwestern Medical Center, Dallas, TX, and approved January 23, 2009 (received for review October 9, 2008) Adaptation to hypoxia is mediated through a coordinated transcrip- promoter or enhancers of Ϸ50 genes (10, 11). Alignment of the tional response driven largely by hypoxia-inducible factor 1 (HIF-1). sequences encompassing these well-characterized functional HREs We used ChIP-chip and gene expression profiling to identify direct (transcriptionally activated by hypoxia) has revealed a consensus HIF- targets of HIF-1 transactivation on a genome-wide scale. Several 1-binding motif (the core HRE) of 5Ј-RCGTG-3Ј (R ϭ AorG). hundred direct HIF-1 targets were identified and, as expected, were Because the core HRE is too promiscuous to accurately predict highly enriched for proteins that facilitate metabolic adaptation to binding a priori, we used ChIP-chip to define HIF-1 chromatin hypoxia. Surprisingly, there was also striking enrichment for the binding on a genome-wide level. We integrated these results with family of 2-oxoglutarate dioxygenases, including the jumonji-domain gene expression profiling to interrogate mechanisms regulating histone demethylases. We demonstrate that these histone demethy- hypoxia-induced gene expression and to more comprehensively lases are direct HIF targets, and their up-regulation helps maintain identify direct targets of HIF-1 transactivation. We found that the epigenetic homeostasis under hypoxic conditions. These results sug- family of 2-oxoglutarate-dependent dioxygenases are coordinately gest that the coordinated increase in expression of several oxygen- targeted by HIF, and up-regulated expression helps maintain global CELL BIOLOGY dependent enzymes by HIF may help compensate for decreased levels levels of histone methylation under hypoxic conditions. of oxygen under conditions of cellular hypoxia. Results ChIP-chip ͉ hypoxia ͉ jumonji protein ͉ dioxygenase ͉ epigenetics Identification of HIF-1-Binding Sites by ChIP-chip. To identify HIF-1- binding sites across the genome, HepG2 cells were grown under dequate oxygenation is essential for normal physiology and both normoxic (ambient) and hypoxic (0.5% O2) conditions, and Afunctioning of all cells. In response to decreased oxygen ChIP was performed by using a HIF-1␣ polyclonal antibody without tension, a coordinated transcriptional response is activated to appreciable cross-reactivity to HIF-2␣ (Fig. S1A). ChIP and input maintain cellular homeostasis. This transcriptional program is DNA were hybridized to Affymetrix GeneChip Human Tiling 2.0R mediated, at least in part, by activation of the heterodimeric Array Sets, consisting of probes covering the entire nonrepetitive transcription factors hypoxia-inducible factor 1 and 2 (HIF-1 and human genome at 35-bp resolution. The model-based analysis for HIF-2). The HIFs are essential for several physiological processes, tiling arrays (MAT) algorithm (12) was used to identify probe signal including normal development, erythropoietin (EPO) production, peaks comparing triplicate biological replicates of HIF-1 ChIP and wound healing. Unfortunately, HIF signaling also contributes DNA to their matched inputs by using an initial P value cutoff of to the pathophysiology of tumors by facilitating metabolic adapta- 1EϪ5. Consistent with the fact that HIF-1␣ protein levels increase tion and by promoting angiogenesis, invasion, and metastasis (1). dramatically in hypoxic compared with normoxic samples (Fig. The activity of HIF-1 and HIF-2 are controlled at multiple levels. S1B), 91% of the putative HIF-1-binding sites were characterized The primary point of regulation is at the level of abundance of the by a positive peak call only under hypoxic conditions (e.g., ENO1 ␣-subunits. Under normal oxygen (normoxic) conditions, HIF-1␣ and INSIG2;Fig.1A). However, because HIF-1␣ is not entirely and HIF-2␣ are hydroxylated by the HIF prolyl hydroxylases absent in normoxia, peaks in which probe intensities were signifi- EGLN1–3, which target the proteins for binding to the von Hippel– cantly increased under hypoxic conditions by comparison with Lindau (vHL) ubiquitin E3 ligase complex and rapid proteosomal normoxia were also retained (e.g., JMJD1A and ZNF292;Fig.1A). degradation (2–6). As oxygen levels drop, prolyl-hydroxylation A minority of peaks (7%) had peak intensities that did not increase decreases, resulting in accumulation of HIF ␣-subunits and het- in hypoxic compared with normoxic samples (e.g., ADI1 and erodimerization with ARNT (HIF-1␤). As a consequence, HIF PHF12;Fig.1A), and these were suspected to be nonspecific. heterodimer levels are nominal under physiologic oxygen levels and increase exponentially with decreasing oxygen tension (7). HIF heterodimers then recruit transcriptional coactivator complexes (8, Author contributions: X.X., M.E.L., J.S.C., M.B., and A.L.K. designed research; X.X. per- formed research; X.X., M.E.L., W.L., J.S.C., X.S.L., and A.L.K. contributed new reagents/ 9), and transactivate target genes containing the cognate hypoxia- analytic tools; X.X., M.E.L., W.L., M.B., X.S.L., and A.L.K. analyzed data; and X.X., M.E.L., and response element (HRE) (1). A.L.K. wrote the paper. The direct transcriptional targets of HIF-1 play important roles in The authors declare no conflict of interest. facilitating both short-term and long-term adaptation to hypoxia (1). This article is a PNAS Direct Submission. Metabolic homeostasis is achieved by shifting from oxidative phos- 1Present address: Division of Biostatistics, Dan L. Duncan Cancer Center, Department of Mo- phorylation to anaerobic glycolysis through increased expression of the lecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. glycolytic enzymes and glucose transporters, inhibition of the TCA 2Present address: Cancer Research U.K., Cambridge Research Institute, Li Ka Shing Centre, cycle, and induction of pH-regulating systems. A second HIF-1- Robinson Way, Cambridge CB2 0RE, United Kingdom. mediated program increases oxygen delivery by inducing vasodilatation, 3To whom correspondence should be addressed. E-mail: andrew࿝[email protected]. increased vascular permeability, enhanced erythropoiesis and angio- This article contains supporting information online at www.pnas.org/cgi/content/full/ genesis. Specific sites of HIF-1 binding have been validated within the 0810067106/DCSupplemental. www.pnas.org͞cgi͞doi͞10.1073͞pnas.0810067106 PNAS Early Edition ͉ 1of6 Downloaded by guest on October 4, 2021 A B A 1) Hypoxia-unique 2) Hypoxia-enriched 3) Nonspecific HRE+ HRE+ HRE- Hypoxia number of hits Distance from transcription start site (bp) Normoxia ←→→→←← C HRE+ HRE- ENO1 INSIG2 JMJD1A ZNF292 ADI1 PHF12 Norm p<0.001 Norm p=0.894 FDR q<0.001 FDR q=0.936 B 120 60 Enrichment score (ES) Enrichment score 30 20 up hypoxia:normoxia down (ChIP/Input) 10 Fig. 2. Distribution of HIF-1-bound sites and association with transactivation. ChIP-qPCR fold enrichment ChIP-qPCR fold 0 (A) Distribution of HIF-1 ChIP hits relative to the TSS of associated genes. (B) hypoxia/normxia Distribution of core HRE-containing HIF-1 hits (HREϩ) relate to the annotated hypoxia/sh-HIF1α structure of associated genes. (C) GSEA analysis of mRNA expression profiles for hypoxic (0.5%O2, 12 h) vs. normoxic cells. Relative expression was rank-ordered by signal-to-noise (S2N) ratios of triplicate hypoxic samples vs. triplicate normoxic ϩ HK2 samples. Genes associated with HRE HIF-1-binding sites were strongly corre- ID2-LR ENO1 DDIT4 INHA LDHA PGK1 P4HB ADI1 PHF12 RNMT ADFP RAB17 EFNA1 NEDD9 INSIG2 NDRG1 ZNF292 ALDOA IFNAR1 PFKFB4 MIG6-176K MIG6-185K BHLHB2-3' RAPGEF6 ANKRD37 KIAA2013 JMJD2B JARID1B SAMHD1 SERPINE1 JMJD1A JMJD2C-LR MGC45491-LR ANKRD15-23K 10kbupVEGF 5KbUpVEGF JMJD2C-prom lated with the hypoxic phenotype. In contrast, no such enrichment was evident 1) 2) 3) for the ChIP-chip fragments without identifiable core HREs (HREϪ). The color bar indicates up-regulated (red, positive S2N) and down-regulated (blue, negative Fig. 1. HIF-1 ChIP-chip analysis and validation. (A) Representative integrated S2N) genes. genome browser (IGB; Affymetrix) tracks showing peaks of probe intensities (vertical bars) arrayed by chromosomal position. For each locus, tracks are scaled identically. ChIP peaks were identified by using the MAT algorithm and were and P value Ͻ 2.5 ϫ 10Ϫ7) that together resulted in high specificity classified as hypoxia-unique, hypoxia-enriched, or nonspecific. (B) ChIP-chip re- (95.5%) and sensitivity (82.5%) (Fig. S1D). Within a subset of 40 sults were validated by ChIP-qPCR using primer pairs surrounding the putative well-validated HIF-1 targets evaluated by ChIP-qPCR (Table S2), binding sites in the indicated loci. For each locus, the fold enrichment comparing HIF-1 ChIP DNA to input is represented in the bar graph (mean Ϯ SD). To these thresholds produced an empiric sensitivity of 75% and determine specificity for HIF-1, the bottom heat map depicts the fold enrichment specificity of 100%. With these optimized thresholds, a total of 377 comparing hypoxic to normoxic cells and control hypoxic cells to cells in which HIF-1-binding sites were identified across the genome. HIF-1␣ was specifically depleted with a lentiviral shRNA (sh-HIF1␣). Primer pairs The canonical motif that is bound by HIF-1, the core HRE, is locate 5 and 10 kb upstream of the VEGF gene were used as controls.
Load more

Recommended publications
  • The Cross-Talk Between Methylation and Phosphorylation in Lymphoid-Specific Helicase Drives Cancer Stem-Like Properties
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans ARTICLE OPEN The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties Na Liu1,2,3, Rui Yang1,2, Ying Shi1,2, Ling Chen1,2, Yating Liu1,2, Zuli Wang1,2, Shouping Liu1,2, Lianlian Ouyang4, Haiyan Wang1,2, Weiwei Lai1,2, Chao Mao1,2, Min Wang1,2, Yan Cheng5, Shuang Liu4, Xiang Wang6, Hu Zhou7, Ya Cao1,2, Desheng Xiao1 and Yongguang Tao1,2,6 Posttranslational modifications (PTMs) of proteins, including chromatin modifiers, play crucial roles in the dynamic alteration of various protein properties and functions including stem-cell properties. However, the roles of Lymphoid-specific helicase (LSH), a DNA methylation modifier, in modulating stem-like properties in cancer are still not clearly clarified. Therefore, exploring PTMs modulation of LSH activity will be of great significance to further understand the function and activity of LSH. Here, we demonstrate that LSH is capable to undergo PTMs, including methylation and phosphorylation. The arginine methyltransferase PRMT5 can methylate LSH at R309 residue, meanwhile, LSH could as well be phosphorylated by MAPK1 kinase at S503 residue. We further show that the accumulation of phosphorylation of LSH at S503 site exhibits downregulation of LSH methylation at R309 residue, which eventually promoting stem-like properties in lung cancer. Whereas, phosphorylation-deficient LSH S503A mutant promotes the accumulation of LSH methylation at R309 residue and attenuates stem-like properties, indicating the critical roles of LSH PTMs in modulating stem-like properties. Thus, our study highlights the importance of the crosstalk between LSH PTMs in determining its activity and function in lung cancer stem-cell maintenance.
    [Show full text]
  • Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression
    International Journal of Molecular Sciences Review Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression Guang Yang, Rachel Shi and Qing Zhang * Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; [email protected] (G.Y.); [email protected] (R.S.) * Correspondence: [email protected]; Tel.: +1-214-645-4671 Received: 6 October 2020; Accepted: 29 October 2020; Published: 31 October 2020 Abstract: Oxygen homeostasis regulation is the most fundamental cellular process for adjusting physiological oxygen variations, and its irregularity leads to various human diseases, including cancer. Hypoxia is closely associated with cancer development, and hypoxia/oxygen-sensing signaling plays critical roles in the modulation of cancer progression. The key molecules of the hypoxia/oxygen-sensing signaling include the transcriptional regulator hypoxia-inducible factor (HIF) which widely controls oxygen responsive genes, the central members of the 2-oxoglutarate (2-OG)-dependent dioxygenases, such as prolyl hydroxylase (PHD or EglN), and an E3 ubiquitin ligase component for HIF degeneration called von Hippel–Lindau (encoding protein pVHL). In this review, we summarize the current knowledge about the canonical hypoxia signaling, HIF transcription factors, and pVHL. In addition, the role of 2-OG-dependent enzymes, such as DNA/RNA-modifying enzymes, JmjC domain-containing enzymes, and prolyl hydroxylases, in gene regulation of cancer progression, is specifically reviewed. We also discuss the therapeutic advancement of targeting hypoxia and oxygen sensing pathways in cancer. Keywords: hypoxia; PHDs; TETs; JmjCs; HIFs 1. Introduction Molecular oxygen serves as a co-factor in many biochemical processes and is fundamental for aerobic organisms to maintain intracellular ATP levels [1,2].
    [Show full text]
  • Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications
    cells Review Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications Rachel Shi, Chengheng Liao and Qing Zhang * Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; [email protected] (R.S.); [email protected] (C.L.) * Correspondence: [email protected]; Tel.: +1-214-645-4671 Abstract: Hypoxia, a common feature of solid tumors, greatly hinders the efficacy of conventional cancer treatments such as chemo-, radio-, and immunotherapy. The depletion of oxygen in proliferat- ing and advanced tumors causes an array of genetic, transcriptional, and metabolic adaptations that promote survival, metastasis, and a clinically malignant phenotype. At the nexus of these intercon- nected pathways are hypoxia-inducible factors (HIFs) which orchestrate transcriptional responses under hypoxia. The following review summarizes current literature regarding effects of hypoxia on DNA repair, metastasis, epithelial-to-mesenchymal transition, the cancer stem cell phenotype, and therapy resistance. We also discuss mechanisms and pathways, such as HIF signaling, mitochon- drial dynamics, exosomes, and the unfolded protein response, that contribute to hypoxia-induced phenotypic changes. Finally, novel therapeutics that target the hypoxic tumor microenvironment or interfere with hypoxia-induced pathways are reviewed. Keywords: hypoxia; metastasis; hypoxia-inducible factors; chemoresistance Citation: Shi, R.; Liao, C.; Zhang, Q. Hypoxia-Driven Effects in Cancer: 1. Introduction Characterization, Mechanisms, and Understanding the mechanisms by which cells sense oxygen and maintain oxygen Therapeutic Implications. Cells 2021, homeostasis is of pivotal importance for science and medicine. Only in recent decades have 10, 678. https://doi.org/10.3390/ breakthrough discoveries of mechanisms for eukaryotic oxygen sensing been made.
    [Show full text]
  • Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy
    Cancers 2011, 3, 1691-1707; doi:10.3390/cancers3021691 OPEN ACCESS cancers ISSN 2072-6694 www.mdpi.com/journal/cancers Review Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy Monica Mann 1, Valerie Cortez 1 and Ratna K. Vadlamudi 2,* 1 Department of Cellular and Structural Biology, UTHSCSA, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA; E-Mails: [email protected] (M.M.); [email protected] (V.C.) 2 Department of Obstetrics and Gynecology, UTHSCSA, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-210-567-4930; Fax: +1-210-567-4958. Received: 4 January 2011; in revised form: 11 March 2011 / Accepted: 25 March 2011 / Published: 29 March 2011 Abstract: Estrogen receptor (ER) signaling plays a key role in hormonal cancer progression. ER is a ligand-dependent transcription factor that modulates gene transcription via recruitment to the target gene chromatin. Emerging evidence suggests that ER signaling has the potential to contribute to epigenetic changes. Estrogen stimulation is shown to induce several histone modifications at the ER target gene promoters including acetylation, phosphorylation and methylation via dynamic interactions with histone modifying enzymes. Deregulation of enzymes involved in the ER-mediated epigenetic pathway could play a vital role in ER driven neoplastic processes. Unlike genetic alterations, epigenetic changes are reversible, and hence offer novel therapeutic opportunities to reverse ERdriven epigenetic changes In this review, we summarize current knowledge on mechanisms by which ER signaling potentiates epigenetic changes in cancer cells via histone modifications.
    [Show full text]
  • Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2010 Molecular Mechanisms Involved Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis Ryan Fassnacht Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Physiology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2246 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Ryan C. Fassnacht 2010 All Rights Reserved Molecular Mechanisms Involved in the Interaction Effects of HCV and Ethanol on Liver Cirrhosis A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University. by Ryan Christopher Fassnacht, B.S. Hampden Sydney University, 2005 M.S. Virginia Commonwealth University, 2010 Director: Valeria Mas, Ph.D., Associate Professor of Surgery and Pathology Division of Transplant Department of Surgery Virginia Commonwealth University Richmond, Virginia July 9, 2010 Acknowledgement The Author wishes to thank his family and close friends for their support. He would also like to thank the members of the molecular transplant team for their help and advice. This project would not have been possible with out the help of Dr. Valeria Mas and her endearing
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Mutant IDH, (R)-2-Hydroxyglutarate, and Cancer
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer Julie-Aurore Losman1 and William G. Kaelin Jr.1,2,3 1Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA; 2Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA Mutations in metabolic enzymes, including isocitrate whether altered cellular metabolism is a cause of cancer dehydrogenase 1 (IDH1) and IDH2, in cancer strongly or merely an adaptive response of cancer cells in the face implicate altered metabolism in tumorigenesis. IDH1 of accelerated cell proliferation is still a topic of some and IDH2 catalyze the interconversion of isocitrate and debate. 2-oxoglutarate (2OG). 2OG is a TCA cycle intermediate The recent identification of cancer-associated muta- and an essential cofactor for many enzymes, including tions in three metabolic enzymes suggests that altered JmjC domain-containing histone demethylases, TET cellular metabolism can indeed be a cause of some 5-methylcytosine hydroxylases, and EglN prolyl-4-hydrox- cancers (Pollard et al. 2003; King et al. 2006; Raimundo ylases. Cancer-associated IDH mutations alter the enzymes et al. 2011). Two of these enzymes, fumarate hydratase such that they reduce 2OG to the structurally similar (FH) and succinate dehydrogenase (SDH), are bone fide metabolite (R)-2-hydroxyglutarate [(R)-2HG]. Here we tumor suppressors, and loss-of-function mutations in FH review what is known about the molecular mechanisms and SDH have been identified in various cancers, in- of transformation by mutant IDH and discuss their im- cluding renal cell carcinomas and paragangliomas.
    [Show full text]
  • An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis Sriram Devanathan Washington University School of Medicine in St. Louis Timothy Whitehead Washington University School of Medicine in St. Louis George G. Schweitzer Washington University School of Medicine in St. Louis Nicole Fettig Washington University School of Medicine in St. Louis Attila Kovacs Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; and Shoghi, Kooresh I., ,"An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis." PLoS One.9,7. e101900. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3326 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Sriram Devanathan, Timothy Whitehead, George G. Schweitzer, Nicole Fettig, Attila Kovacs, Kenneth S. Korach, Brian N. Finck, and Kooresh I. Shoghi This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3326 An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis Sriram Devanathan1, Timothy Whitehead1, George G. Schweitzer2, Nicole Fettig1, Attila Kovacs3, Kenneth S.
    [Show full text]
  • Histone Demethylase JMJD6 Regulates Cellular Migration And
    Shen et al. Stem Cell Research & Therapy (2018) 9:212 https://doi.org/10.1186/s13287-018-0949-3 RESEARCH Open Access Histone demethylase JMJD6 regulates cellular migration and proliferation in adipose-derived mesenchymal stem cells Chongyang Shen1,2, Qingli Quan3*, Chuan Yang1, Yueqiang Wen2 and Hong Li1* Abstract Background: Adipose-derived mesenchymal stem cells (ADSCs) have been extensively explored as a promising therapeutic agent due to their differentiation, proliferation and migration abilities. The epigenetic mechanisms that regulate the fate of mesenchymal stem cells (MSCs) have been described in detail. However, the epigenetic modulation of ADSCs proliferation and migration is poorly understood. Methods: The present study examined histone demethylases roles and expression by RT-PCR, as well as through siRNA screening and ChIP-qPCR assay. Cellular proliferation and migration assays were employed in shRNA- mediated JMJD6 knockdown and control ADSCs. PDE1C inhibition studies were conducted to confirm its role in JMJD6-mediated epigenetic regulation of ADSCs. Results: The data demonstrate that the histone demethylase JMJD6 plays a critical role in regulating the proliferation and migration of ADSCs by removing H4R3me2a at the promoter regions of PDEC1 and suppressing PDEC1 expression. Importantly, the depletion of JMJD6 in ADSCs significantly increased cellular proliferation and motility, which was associated with increases in PDE1C expression and decreases in the levels of both cAMP and cGMP. The increase in proliferation and migration was reversed by treatment with a PDE1C inhibitor, suggesting that JMJD6 attenuates the proliferation and migration of ADSCs as an epigenetic regulator and PDE1C partially contributes to the JMJD6-mediated regulation. Conclusions: Taken together, our results indicate for the first time that JMJD6 plays an important role in the regulation of ADSCs proliferation and migration through the modulation of PDE1C expression.
    [Show full text]
  • ARTICLE Doi:10.1038/Nature10523
    ARTICLE doi:10.1038/nature10523 Spatio-temporal transcriptome of the human brain Hyo Jung Kang1*, Yuka Imamura Kawasawa1*, Feng Cheng1*, Ying Zhu1*, Xuming Xu1*, Mingfeng Li1*, Andre´ M. M. Sousa1,2, Mihovil Pletikos1,3, Kyle A. Meyer1, Goran Sedmak1,3, Tobias Guennel4, Yurae Shin1, Matthew B. Johnson1,Zˇeljka Krsnik1, Simone Mayer1,5, Sofia Fertuzinhos1, Sheila Umlauf6, Steven N. Lisgo7, Alexander Vortmeyer8, Daniel R. Weinberger9, Shrikant Mane6, Thomas M. Hyde9,10, Anita Huttner8, Mark Reimers4, Joel E. Kleinman9 & Nenad Sˇestan1 Brain development and function depend on the precise regulation of gene expression. However, our understanding of the complexity and dynamics of the transcriptome of the human brain is incomplete. Here we report the generation and analysis of exon-level transcriptome and associated genotyping data, representing males and females of different ethnicities, from multiple brain regions and neocortical areas of developing and adult post-mortem human brains. We found that 86 per cent of the genes analysed were expressed, and that 90 per cent of these were differentially regulated at the whole-transcript or exon level across brain regions and/or time. The majority of these spatio-temporal differences were detected before birth, with subsequent increases in the similarity among regional transcriptomes. The transcriptome is organized into distinct co-expression networks, and shows sex-biased gene expression and exon usage. We also profiled trajectories of genes associated with neurobiological categories and diseases, and identified associations between single nucleotide polymorphisms and gene expression. This study provides a comprehensive data set on the human brain transcriptome and insights into the transcriptional foundations of human neurodevelopment.
    [Show full text]
  • Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma by Andrea Shergalis
    Preclinical Evaluation of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma By Andrea Shergalis A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Medicinal Chemistry) in the University of Michigan 2020 Doctoral Committee: Professor Nouri Neamati, Chair Professor George A. Garcia Professor Peter J. H. Scott Professor Shaomeng Wang Andrea G. Shergalis [email protected] ORCID 0000-0002-1155-1583 © Andrea Shergalis 2020 All Rights Reserved ACKNOWLEDGEMENTS So many people have been involved in bringing this project to life and making this dissertation possible. First, I want to thank my advisor, Prof. Nouri Neamati, for his guidance, encouragement, and patience. Prof. Neamati instilled an enthusiasm in me for science and drug discovery, while allowing me the space to independently explore complex biochemical problems, and I am grateful for his kind and patient mentorship. I also thank my committee members, Profs. George Garcia, Peter Scott, and Shaomeng Wang, for their patience, guidance, and support throughout my graduate career. I am thankful to them for taking time to meet with me and have thoughtful conversations about medicinal chemistry and science in general. From the Neamati lab, I would like to thank so many. First and foremost, I have to thank Shuzo Tamara for being an incredible, kind, and patient teacher and mentor. Shuzo is one of the hardest workers I know. In addition to a strong work ethic, he taught me pretty much everything I know and laid the foundation for the article published as Chapter 3 of this dissertation. The work published in this dissertation really began with the initial identification of PDI as a target by Shili Xu, and I am grateful for his advice and guidance (from afar!).
    [Show full text]
  • The Dynamic Role of Jumonji C Domain Containing Protein 6 in Placental Development and Disease
    The Dynamic Role of Jumonji C Domain Containing Protein 6 in Placental Development and Disease by Sruthi Alahari A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Physiology University of Toronto © Copyright by Sruthi Alahari 2017 i The Dynamic Role of Jumonji C Domain Containing Protein 6 in Placental Development and Disease Sruthi Alahari Doctor of Philosophy Department of Physiology University of Toronto 2017 Abstract Perturbations in oxygen sensing are a defining feature of placental-associated pathologies such as preeclampsia, a serious disorder of pregnancy. Preeclamptic placentae have markedly elevated levels of Hypoxia Inducible Factor 1α (HIF1A), a master regulator of oxygen homeostasis. Mounting evidence implicates a family of Fe2+ and oxygen-dependent Jumonji C domain containing enzymes (JMJDs) as mediators of the epigenetic code and hypoxic gene expression. While several JMJDs are induced in hypoxia, their role in pregnancy remains unclear. The goal of this study was to characterize JMJD6 function in the placenta in physiological and pathological conditions, and unravel its regulatory relationship with von Hippel Lindau tumour suppressor (VHL), a key executor of the cellular hypoxic response. JMJD6 expression inversely correlated with changes in oxygen tension during placental development, while JMJD6 protein and mRNA were significantly elevated in low oxygen and in early-onset preeclamptic (E-PE) placentae. In vitro demethylation assays revealed that optimal JMJD6-dependent demethylation of its histone targets, H3R2me2s and H4R3me2s, occurred in normoxia, and this was impaired in E-PE placentae due to a hypoxia-iron imbalance. In cytotrophoblast cells, JMJD6 is a positive ii regulator of VHL gene expression in normoxia.
    [Show full text]